Systemic inflammation as a confounding factor in cancer biomarker discovery and validation

Nature Reviews Cancer

Volumn 10, Issue 1, 2010, Pages 2-3

  Chechlinska, Magdalena ^a   Kowalewska, Magdalena ^a   Nowak, Radoslawa ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19; CYTOKERATIN 20;

CANCER CELL; CANCER PATIENT; CELL INFILTRATION; ERYTHROCYTE SEDIMENTATION RATE; GENE EXPRESSION; GENOME; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; METABOLITE; MICROENVIRONMENT; NOTE; PHENOTYPE; PRIORITY JOURNAL; PROTEOMICS; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA; VALIDATION STUDY;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 72949083963     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc2782     Document Type: Note

References (12)

1. Mantovani, A. Inflaming metastasis. Nature 457, 36-37 (2009).
2. Hanas, J. S. et al. Biomarker identification in human pancreatic cancer sera. Pancreas 36, 61-69 (2008).
3. Maciel, C. M. et al. Differential proteomic serum pattern of low molecular weight proteins expressed by adenocarcinoma lung cancer patients. J. Exp. Ther. Oncol. 5, 31-38 (2005).
4. Tebib, J. G., Reynaud, C., Cedoz, J. P., Letroublon, M. C. & Niveleau, A. Relationship between urinary excretion of modified nucleosides and rheumatoid arthritis process. Br. J. Rheumatol 36, 990-995 (1997).
5. Yang, J. et al. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 813, 59-65 (2004).
6. Ziegler, A., Zangemeister-Wittke, U. & Stahel, R. A. Circulating DNA: a new diagnostic gold mine? Cancer Treat Rev. 28, 255-271 (2002).
7. Sharma, P. et al. Detection of altered global DNA methylation in coronary artery disease patients. DNA Cell Biol. 27, 357-365 (2008).
8. Jung, R. et al. Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro. Br. J. Cancer 78, 1194-1198 (1998).
9. Kowalewska, M., Chechlinska, M., Markowicz, S., Kober, P. & Nowak, R. The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regarded as tumour-specific in activated lymphocytes. Eur. J. Cancer 42, 2671-2674 (2006).
10. Dimmler, A. et al. Transcription of cytokeratins 8, 18, and 19 in bone marrow and limited expression of cytokeratins 7 and 20 by carcinoma cells: inherent limitations for RT-PCR in the detection of isolated tumor cells. Lab. Invest. 81, 1351-1361 (2001).
11. Schuster, R. et al. Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers. Int. J. Cancer 108, 219-227 (2004).
12. Liu, L. et al. Detection of circulating cancer cells in lung cancer patients with a panel of marker genes. Biochem. Biophys. Res. Commun. 372, 756-760 (2008).